In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

 
Related

How to celebrate Valentine's Day After Marriage

Good News
272 points

Getting Married Is Not an Accomplishment

Good News
784 points



Most recent

Terrifying amount of prey spiders devour each year revealed for the first time

Amazing news
58 points

LA BURBUJA

Hector Valencia Baldoni
52 points

The world's first smart condom is here to change your sex life forever

Crazy stuff
378 points

There is a sanctuary in Hawaii where you can cuddle hundreds of fluffy cats

Animals
338 points

What the way you sit reveals about your personality

Crazy stuff
498 points

A woman leaves her car in the restaurant parking lot, then finds an unexpected note

Luffy News
304 points

Police dog is shot in the line of duty, has priceless reaction when he reunites with cop

Animals
18 points

Police force admits to investigating FLYING SAUCERS after raft of calls about terrified 'aliens'

Amazing news
106 points

These 2 ingredients can save your feet without expensive pedicure

About everything
820 points

If you have dogs or cats, you should read this!

Animals
36 points
SHARE
TWEET
An experimental drug combination dissolved a cancerous tumor so fast, it caught researchers completely off-guard. The two-drug combo completely eliminated a woman’s melanoma — and left her completely cancer-free — in just three weeks.

In Successful Cancer Trial, Therapy "Dissolves" Stage IV Tumor in 3 Weeks

Researchers were surprised at how well the drug combination worked, shrinking tumors at least 80% in more than half of the 142 patients in the trial. And the combination completely eradicated tumors in 22% of patients.

In the rapid recovery case, a 49-year-old woman was given the drugs to treat a large tumor on her chest. Doctors continued to monitor her after the treatment and she remains cancer-free. (The image on the left shows the cancer mass with an asterisk* and the photo on the right is magnified)

“I was astonished; I’d never seen anything like that,” Dr. Paul Chapman, head of the melanoma section at the Memorial Sloan Kettering Cancer Center in New York told Live Science. “She said the tumor had just kind of dissolved.”

Chapman was lead author of the research report published in the New England Journal of Medicine about the trial, part of research needed for the FDA to approve combined use of the drugs.

The woman, and others in the trial, were treated with a process called immunotherapy — using drugs to boost a person’s own immune system to fight cancer. It’s a relatively new approach to treating deadly melanoma.

he patients were given two FDA-approved melonoma drugs already being used to treat the cancer, but not used in combination before — ipilimumab (sold under the brand name Yervoy) and nivolumab (brand name Opdivo).

Ipilimumab allows the body to override part of the immune system, turning loose waves of immune cells to kill cancer cells. Nivolumab strengthens certain immune cells, called “T cells,” preventing them from dying and allowing them to continue attacking cancer longer.

Chapman says the tests confirm a suspicion doctors and researchers have had for a long time that the immune system can fight cancer. This research may open new doors in unleashing that potential.

Fuente: www.goodnewsnetwork.org
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content